Frequently Asked Questions about Todos Q: I read on a

New Post Public Reply Private Reply Replies (1) Message Board
redspeed
413
Frequently Asked Questions about Todos

Q: I read on a message board Todos was going to have a Super Bowl Commercial. Is that true?
A: A 30 second Superbowl commercial is $6M. Don't get your investment information off of a message board, twitter, etc. Todos is however sponsoring the Celeb Flag Football Game with some big stars next weekend.

Q: Does anyone watch the Celeb Flag Football Game? Why would any company sponsor it?
A: Truist Financial Corporation, a $85B company sponsored it 2 of the last 3 years. They are a top 10 U.S. commercial bank with total assets of $530 billion. I think they know a think or two about marketing, since their name is on a lot of sports arenas.

Q: How is the company going to make money. Isn't the pandemic over?
A: Sure. I guess it was over two years ago too.

Q: The positive Tollovir data was released week ago!!! Why hasn't there been EUAs, contracts, partnerships and buyout already?
A: It's unrealistic to think any of those would happen in a week for any company unless you have ACD.

Q: Don't you mean ADD?
A: ACD

Q: The NLC Pharma deal hasn't closed yet. They are making all the money, not Todos. Do they want out?
A: International deals take time to close. Average non international deal takes over 3 months. There is already a partnership agreement in place that both companies are operating on. Todos is pulling in plenty of revenue from Tollovid.

Q: My bottle of Tollovid Daily is dated August 2021. Is it not selling well. Why am I getting cheated out of 6 months when the shelf life is 2 years.
A: Some manufacturers put a 'made date' on. Others put an expiration. My bottle of Aleve from Costco expired in 18 months, but I don't feel cheated. Todos does big production runs when they can get a spot. Once they have their own manufacturing, they can produce daily instead. BTW, if you are buying Tollovid daily, it should last you 30 to 60 days at most so having a year plus is a benefit. It's also plant based and not likely to expire overnight either.

Q: Does Tollovid have any side effects? I read it may turn my stool darker and/or you'll get bad gas, diarrhea, etc.
A: The company has said, there are no known side effects other than turning your stool darker which a lot of things do, including red wine. The company said diarrhea, gas, etc. are known symptoms of Covid. Tollovid does not cause it and it's your body reacting to getting rid of the virus. The virus is shedding the virus through your gastro track.

Q: Where is Tollovid manufactured? I read on a message board it was China.
A: USA. Says so on the bottle, website and the company has talked about it a lot. One of the international selling points is, it's made in the USA instead of a dumpy plant in god knows where. Also had FDA approval of free sale.

Q: Why doesn't the company give us a daily update on how many tests they sold, how many tests they processed in the lab and how many bottles of Tollovid they sold?
A: Because that would be material information and it's why companies report quarterly. If you want a stock that counts everything, buy McDonald's and look at the sign outside. Oh, that's right, even they stopped that.

Q: Why doesn't the CEO answer all my questions and concerns on twitter? I demand to know everything that is going on.
A: If you want that, you may be in the wrong investment. Check out savings bonds.

Q: Why the the CEO spending all his time on Twitter?
A: It's actually a handful of minutes if we are not exaggerating, but it's called education and marketing. You don't get on major networks by hiding in the corner.

Q: I heard Todos has very good Covid tests like CPASS and Tollotest and makes a lot of money being a distributor on others supplying labs. Are there any other test coming out on the market and is it competition for Todos? I know viruses mutate and spread quickly, which has me 'concerned'.
A: Funny you should ask...

1884824279_AssO-CTest.jpg

Q: How long before I can see the results to see if I test positive for Assclown?
A: About 2 seconds

Q: It's there any cure for the Assclown if I test positive?
A: In rare circumstances, if you stand in front of mirror and say "I'm an Assclown" 3 times, there is sometimes an awaken in 1% of the cases. Usually once an Assclown, you have to live with it and the reduced quality of life.

Q: What are the symptoms of Assclown?
A: There are a lot...
Shortness of breath or difficulty breathing
Loss sense of reality
Histrionic personality disorder
Low Self-esteem
Low Self-awareness
Nausea or vomiting on ones clothes and blaming others
Nonstop Explosive Diarrhea
Skid Marks
Restraining Orders
No Accountability
Impotence
Severe Shrinkage
Retracted or Undescended Testicles
Manic Depressive
BiPolar
Extreme financial loss of the nest egg
Living in mom's basement or with your child
Sore fingers
Paranoia
Napoleon complex
Obsessive compulsive
Fatigue
Muscle or body aches
Headache
Afraid of clowns

Yeah, I don't get the last one either. Seems ironic, eh?

Q: What's the market for the AssO-CTest and who would take it?
A: Larger than you would think. Just look at social media and message boards. Direct marketing would target Assclowns as they have an uncanny need to prove they aren't Assclowns but you don't need AI to spot them as they stick out like a sore thumb.

Q: I am a new investors, but why are there posters like Sapientlife, JPetroInc (John W Petrosino from Planet Neptune) and others spamming social media and message boards post all day, every day, trashing companies. Are they financial advisors or something? Don't they have a real jobbie? Why do they want to block life saving drugs to market?
A: They haven't taken the AssO-CTest yet, so unaware they are Assclowns. They are giving financial advice on social media without a license and on investor calls. That is illegal.
I hear employers may fire them shortly, if they haven't already, for milking taxpayers out of tens of thousands of dollars for doing nothing.

Q: Is there something we investors can do about it?
A: Besides the doctor that is schooling JP on drugs, it's in motion. Watch him throw a big tantrum when he realizes the gravity of it all. I have the means and motivation to take legal action. Can't wait for the legal defense when they pull up posts like this and the jury laughs their asses off.
JP: "Judge, I have the CEO blogs"
Judge: "Sit your arse down, clown!"
When I have time, I'll post some examples of when pumpers/bashers, paid an incredible legal price. Sucks to lose your house and life savings, but that low/no awareness a major symptom of being infected with Assclown.
JP: "Judge, I assclown disease"
Judge: "You got that right but it's not an excuse for being inhuman"

The above is created by an investor based on his observations, support for his personal investments and should not be taken as communication from the company nor investment advice.

Talk to your doctor, financial advisor or Assclown consular for help making decisions and don't get it off a message boards.

Assclown disease is not to be taken lightly and the Assclown pandemic isn't over.

Todos Med Ltd. (TOMDF) Stock Research Links

TOMDF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Truist Revolutionizes Banking with 2 Billion Insights

Updated Category News Views 0

A New Frontier in Banking Truist is out here flipping the script in digital banking, pushing a staggering 2 billion AI-driven insights since 2023. Imagine that—two billion insights 'till now, providing the kind of financial street smarts that help folks feel less like they're lost at sea and more like they're the captain of their own financial ship, all thanks to Truist...

Continue Reading
Zum Drivers Shine as New School Year Begins

Updated Category News Views 1

Opening the School Year with High Hopes Zum's crew of enthusiastic drivers hit the streets with a mission: kickstarting the new school year with a sense of excitement that feels fresh, even to a grizzled trader like me. These folks are doing more than just turning the ignition, they’re handling a vital cog in the education machine. From Fresno down to Rockford, you’ll...

Continue Reading
L.L.Bean Teams with Drake and Ann Michael Maye

Updated Category News Views 2

The New Faces of L.L.Bean's Tradition Ah, here we go again with L.L.Bean, spicing things up with a bit of southern flair. This time they've reeled in the Mayes—Drake, that hotshot quarterback from the Patriots, and his better half, Ann Michael. A surprise duo, sure, but that's the kind of refresh the century-old brand could use. They’re all about making New England...

Continue Reading
Eluvio's Broadcast Revolution: Zero-Copy AI Streaming

Updated Category News Views 1

The Game-Changing Shift in Broadcast Tech Eluvio's latest reveal at IBC 2026 shows they've taken the gloves off in the broadcast arena. They're pitching an all-in-one Global Broadcast Fabric that's turning heads with its zero-copy distribution and inline AI capabilities. No more dilly-dallying with satellites or cumbersome cloud solutions. Instead, they've cut right to...

Continue Reading
Catholic Colleges Excel in AI Readiness, Study Shows

Updated Category News Views 1

Faith and Tech: An Unexpected Alliance? Alright, here's something that'll make you sit up: Catholic college grads are not just busy sipping their morning coffee while they muse over moral philosophy—they're out there on the front lines of artificial intelligence, better prepared and more engaged than their peers from secular schools. According to the latest Holistic...

Continue Reading
DUNKMAN's Slam Dunk Expansion Plans for 2027

Updated Category News Views 1

More Than Just A Dunk Contest You ever heard of a slam dunk that turns into something bigger than the game itself? Well, Shaquille O'Neal's DUNKMAN is proving just that. Born from the vision of O'Neal and Authentic Brands Group, this beast of an entity isn't just about dunks anymore—it's a whole darn league carving out space in the sporting world. From Inaugural Sparks...

Continue Reading
Pulnovo's PADN System Revolutionizes PH-LHD Treatment

Updated Category News Views 0

Pulnovo's Breakthrough in Heart Disease Management When Pulnovo Medical rolled out the PADN-HF-PH trial results at the ESC Congress 2026, seasoned investors like me sat up and took note. The trial, hot off the presses in The New England Journal of Medicine, unveiled how Pulmonary Artery Denervation (PADN) is throwing a wrench into the gears of conventional treatment of...

Continue Reading
Perspecta's Study Reveals Troubling Data Accuracy Gaps

Updated Category News Views 0

Data Accuracy in Healthcare: A Persistent Problem Just when you think data's about numbers and cold, hard facts, healthcare jolts you awake. Perspecta's fresh insights onto provider data accuracy aren't just a snooze fest of statistics but a genuine wake-up call. This report peels open a can of worms some might prefer to ignore. With only half of provider data accurate,...

Continue Reading
Graphic Packaging Names Berardinelli as HR Executive

Updated Category News Views 1

A New Chapter in HR Leadership at Graphic Packaging September 8 marks a turning point for Graphic Packaging Holding Company with the appointment of Tatiana Berardinelli as their new Chief Human Resources Officer. As NYSE:GPK positions itself for ambitious growth, Berardinelli stands out for her knack for managing transformations and building cultures that thrive in...

Continue Reading
Spencer Spirit Completes Hot Topic Acquisition

Updated Category News Views 2

Merging Forces in Retail In the latest retail reshuffle, Spencer Spirit Holdings has wrapped up its acquisition of Hot Topic, Inc., alongside its eclectic sub-brands: BoxLunch and Her Universe. This move doubles down on Spencer Spirit's ambitions to tighten its grip on the mall-based specialty retail game. If you're an investor looking for a shake-up that could redefine...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Announcement for MGP Ingredients, Inc. Investors

Updated Category News Views 264

Investigation of MGP Ingredients, Inc. Shares Kessler Topaz Meltzer & Check, LLP is actively investigating potential violations of federal securities laws related to MGP Ingredients, Inc. (NASDAQ: MGPI). This inquiry is particularly aimed at investors who have experienced significant losses and who may have been affected by the company’s revised financial outlook and...

Continue Reading
QinetiQ US Advances Future Capabilities in Army Integration

Updated Category News Views 114

QinetiQ US Advances Battlefield Capabilities QinetiQ US is enhancing battlefield capabilities through its participation in the Future Advanced Long-range Common Optical/Netted-fires Sensor (FALCONS) program. This program plays a pivotal role in advancing target acquisition technologies essential for modern military operations. Innovative System Integration Leveraging its...

Continue Reading
Moe Jeudy-Lamour Launches Innovative Thenar Workout Routine

Updated Category News Views 144

Introducing the Thenar Workout by Moe Jeudy-Lamour Fitness enthusiasts, get ready for a new workout trend that centers around an often-overlooked part of the body: the thumbs! Moe Jeudy-Lamour, renowned for his role in the hit series 'Ted Lasso,' is teaming up with Clean Cult to unveil the Thenar Workout. This innovative approach not only emphasizes thumb strength but is...

Continue Reading
Fannie Mae to Release Financial Results and Host Webcast Event

Updated Category News Views 154

Fannie Mae Plans Financial Results Announcement Fannie Mae, a leader in the mortgage finance industry, has made plans to announce its financial results for the second quarter of 2025. This exciting update will take place before the opening of U.S. financial markets, providing investors with crucial information on the company’s performance. Scheduled Date for Financial...

Continue Reading
The Rise of Radiopharmaceutical CDMO Market and Future Prospects

Updated Category News Views 199

Understanding the Radiopharmaceutical CDMO Market Growth As the medical field increasingly embraces advanced technologies, the Radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) market is projected to experience significant growth. According to recent analyses, this market was valued at approximately USD 2.95 billion in the previous year, with...

Continue Reading